🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a prospective, randomized, open-label, multicenter phase III study ...
Status
Recruiting
Location
Zhimin Cancer Shao
Start Date
2024-04-02
Trial ID
NCT06341621
Treatments Being Tested
The purpose of this study was to demonstrate superiority of treatment with ...
Status
Completed
Location
Rocky Mountain Cancer Centers 1800 Williams Street, Suite 100
Start Date
2015-12-28
Trial ID
NCT02625623
Treatments Being Tested
Researchers are looking for new ways to treat people with endometrial cance...
Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Start Date
2023-12-06
Trial ID
NCT06132958
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
A tissue biopsy is currently the only clinical test or procedure that is ab...
Status
Active Not Recruiting
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2019-06-18
Trial ID
NCT03896620
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
This randomized phase II/III trial studies how well cediranib maleate and o...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-03
Trial ID
NCT02502266